Sennesael J J, Maes V A, Pierard D, Debeukelaer S H, Verbeelen D L
Department of Clinical Chemistry, Akademisch Ziekenhuis, Vrije Universiteit Brussel, Belgium.
Am J Nephrol. 1990;10(5):422-5. doi: 10.1159/000168161.
Relapsing peritonitis due to Mycobacterium xenopi developed in an 80-year-old man undergoing continuous peritoneal dialysis after appropriately treated concurrent bacterial peritonitis. The patient presented with a lymphocytic exudative peritoneal drainage fluid. The diagnosis of tuberculous peritonitis was made by identification of acid-fast bacilli in peritoneal effluent and culture of M. xenopi. Oral antituberculous drugs in combination with intraperitoneal streptomycin achieved suppression of the disease, permitting peritoneal dialysis to be continued with satisfactory clearance and ultrafiltration capacity during a follow-up period of up to 35 months. Streptomycin kinetics revealed that 75% of the intraperitoneally administered dose of streptomycin is absorbed from the dialysate.
一名80岁接受持续腹膜透析的男性患者，在恰当治疗并发细菌性腹膜炎后发生了由偶发分枝杆菌引起的复发性腹膜炎。患者的腹膜引流液为淋巴细胞性渗出液。通过在腹膜渗出液中鉴定出抗酸杆菌以及偶发分枝杆菌培养，确诊为结核性腹膜炎。口服抗结核药物联合腹腔内注射链霉素使病情得到控制，在长达35个月的随访期内，腹膜透析得以继续进行，清除率和超滤能力令人满意。链霉素动力学研究表明，腹腔内注射剂量的75%的链霉素可从透析液中吸收。
